Zeng, Yue-Can <br/><br/>
Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Jul 2014 
 - 48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-014-0048-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Brain Neoplasms--mortality<br/>CA-125 Antigen--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Female<br/>Humans<br/>Lung Neoplasms--blood<br/>Male<br/>Membrane Proteins--blood<br/>Middle Aged<br/>Multivariate Analysis<br/>Prognosis<br/>Survival Rate<br/>Tumor Burden